Please Wait
Applying Filters...
menu
    • menu
    Tiefenbacher Group-PSE
    News
    Lindus Health, Tiefenbacher Group Launch ME/CFS Clinical Trial

    06 Mar 2025

    // PR NEWSWIRE

    Tiefenbacher Group Renovation Of Headquarters In Hamburg

    02 May 2024

    // PRESS RELEASE

    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.

    09 Apr 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Tiefenbacher Group

    Contact Supplier

    Website

    Immuno-Oncology 360

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/pmc-isochem/your-partner-for-smart-custom-manufacturing
    Menu

    Tiefenbacher Group

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-group-party-content-21386.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-group-party-content-26459.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Tiefenbacher Group & OnDosis Enter Strategic Partnership

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-group-party-content-7484.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Lindus Health, Tiefenbacher Group Launch ME/CFS Clinical Trial
    Lindus Health, Tiefenbacher Group Launch ME/CFS Clinical Trial

    06 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lindus-health-and-tiefenbacher-group-launching-clinical-trial-to-advance-mecfs-research-and-treatment-302393805.html

    PR NEWSWIRE
    06 Mar 2025
    Share Share
    Tiefenbacher Group Renovation Of Headquarters In Hamburg
    Tiefenbacher Group Renovation Of Headquarters In Hamburg

    02 May 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/05/02/tiefenbacher-group-renovation-of-headquarters-in-hamburg/

    PRESS RELEASE
    02 May 2024
    Share Share
    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.
    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.

    09 Apr 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/04/09/tiefenbacher-first-to-market-launch-rivaroxaban/

    PRESS RELEASE
    09 Apr 2024
    Share Share
    Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
    Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate

    08 Apr 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/04/08/tiefenbacher-group-welcomes-new-coo-sandip-tarate/

    PRESS RELEASE
    08 Apr 2024
    Share Share
    Tiefenbacher Group awarded the EcoVadis Silver Medal!
    Tiefenbacher Group awarded the EcoVadis Silver Medal!

    19 Mar 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/03/19/tiefenbacher-group-awarded-ecovadis-silver-medal/

    PRESS RELEASE
    19 Mar 2024
    Share Share
    Tiefenbacher Group on awareness for rare disease day
    Tiefenbacher Group on awareness for rare disease day

    29 Feb 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/02/29/tiefenbacher-group-on-awareness-for-rare-disease-day/

    PRESS RELEASE
    29 Feb 2024
    Share Share